ResMed Inc. vs Invesco Solar ETF — how do they compare? ResMed Inc. trades at $221.22 (market cap $32.61B), while Invesco Solar ETF trades at $53.77. The key difference: ResMed Inc. pays a 1.17% dividend while Invesco Solar ETF pays none, and Invesco Solar ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | TAN | |
|---|---|---|
Market Cap | $32.61B | — |
Sector | Health | Sector/Thematic |
52-Week High | $293.73 | $73.95 |
52-Week Low | $182.82 | $36.62 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.17% | — |
Trailing returns across standard periods
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →